Latest news
Loading news…
Liminatus Pharma
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Wilmington, Delaware, United States Founded 2018 1-10 employees For Profit
Liminatus Pharma is a immuno‑oncology company offering CD47‑blockade antibody solutions to prevent anemia and thrombocytopenia.
Liminatus Pharma on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Total Funding
$35.9M
Funding Rounds
3
Last Funding
Acquisitions
1
Monthly Visits
Contacts
0
Ticker
LIMN
NASDAQ
About Liminatus Pharma
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- LIMN
- Exchange
- NASDAQ
- IPO date
- Apr 30, 2025
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- IT spend
- $226.92K
Company Info
- Founded
- 2018
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 58
- HQ
- Wilmington, Delaware, United States
- Region
- Greater Philadelphia Area, East Coast, Southern US
- Exit date
- Apr 30, 2025
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -1
- Trend (30d)
- -1.9
- Trend (90d)
- 7
Liminatus Pharma Funding Rounds
3 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–3 of 3Show
Page 1 / 1
Liminatus Pharma Acquisitions
1 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| InnocsAI | $320M | 2026-05-17 | Liminatus Pharma | BiotechnologyOncologyPharmaceutical | — |
1–1 of 1Show
Page 1 / 1
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Liminatus Pharma
Loading news…
FAQs about Liminatus Pharma
People who checked this page also checked these
Sectors Liminatus Pharma invests & acquires in
Browse the full Acquirezy directory.